Market Overview

Morning Market Movers

Share:
Related SOMX
Pernix Therapeutics Completes Acquisition of Somaxon Pharmaceuticals
Somaxon Reports Paladin Labs Wins Health Canada Approval of NDS for Silenor
Related PTX
Brean: Pernix Deal Could Occur Soon, Stock Worth $8
Benzinga's M&A Chatter for Monday February 8, 2016

Somaxon Pharmaceuticals (NASDAQ: SOMX) surged 93.20% to $2.84 at 9:45 am. Somaxon Pharma agreed to be acquired by Pernix Therapeutics Holdings (AMEX: PTX).

TNS (NYSE: TNS) climbed 43.54% to $20.90. TNS agreed to be bought by an affiliate of Siris Capital Group for $21.00 per share.

Zions Bancorporation (NASDAQ: ZIONZ) surged 34.84% to $2.09.

BG Medicine (NASDAQ: BGMD) shares advanced 24.06% to $1.65. BG Medicine obtained a CE Mark enabling the commercial sale of the CardioSCORE(TM) test in the EU.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers

 

Related Articles (PTX + BGMD)

View Comments and Join the Discussion!

Get Benzinga's Newsletters